全文获取类型
收费全文 | 59517篇 |
免费 | 4090篇 |
国内免费 | 226篇 |
专业分类
耳鼻咽喉 | 688篇 |
儿科学 | 1518篇 |
妇产科学 | 1109篇 |
基础医学 | 7416篇 |
口腔科学 | 976篇 |
临床医学 | 5726篇 |
内科学 | 12172篇 |
皮肤病学 | 769篇 |
神经病学 | 5815篇 |
特种医学 | 1990篇 |
外国民族医学 | 4篇 |
外科学 | 10127篇 |
综合类 | 826篇 |
现状与发展 | 1篇 |
一般理论 | 70篇 |
预防医学 | 5224篇 |
眼科学 | 1219篇 |
药学 | 3664篇 |
中国医学 | 62篇 |
肿瘤学 | 4457篇 |
出版年
2023年 | 223篇 |
2022年 | 427篇 |
2021年 | 1011篇 |
2020年 | 571篇 |
2019年 | 966篇 |
2018年 | 1181篇 |
2017年 | 814篇 |
2016年 | 911篇 |
2015年 | 1021篇 |
2014年 | 1680篇 |
2013年 | 2497篇 |
2012年 | 3650篇 |
2011年 | 3952篇 |
2010年 | 2223篇 |
2009年 | 2064篇 |
2008年 | 3579篇 |
2007年 | 3748篇 |
2006年 | 3746篇 |
2005年 | 3804篇 |
2004年 | 3755篇 |
2003年 | 3421篇 |
2002年 | 3363篇 |
2001年 | 558篇 |
2000年 | 431篇 |
1999年 | 644篇 |
1998年 | 779篇 |
1997年 | 656篇 |
1996年 | 587篇 |
1995年 | 558篇 |
1994年 | 491篇 |
1993年 | 451篇 |
1992年 | 399篇 |
1991年 | 402篇 |
1990年 | 336篇 |
1989年 | 346篇 |
1988年 | 310篇 |
1987年 | 314篇 |
1986年 | 284篇 |
1985年 | 333篇 |
1984年 | 503篇 |
1983年 | 421篇 |
1982年 | 528篇 |
1981年 | 519篇 |
1980年 | 514篇 |
1979年 | 272篇 |
1978年 | 301篇 |
1977年 | 297篇 |
1976年 | 237篇 |
1975年 | 236篇 |
1974年 | 239篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
Comparative in vivo evaluation of technetium and iodine labels on an anti-HER2 affibody for single-photon imaging of HER2 expression in tumors. 总被引:1,自引:0,他引:1
Anna Orlova Fredrik Y Nilsson Maria Wikman Charles Widstr?m Stefan St?hl J?rgen Carlsson Vladimir Tolmachev 《Journal of nuclear medicine》2006,47(3):512-519
In vivo diagnosis with cancer-specific targeting agents that have optimal characteristics for imaging is an important development in treatment planning for cancer patients. Overexpression of the HER2 antigen is high in several types of carcinomas and has predictive and prognostic value, especially for breast cancer. A new type of targeting agent, the Affibody molecule, was described recently. An Affibody dimer, His6-(ZHER2:4)2 (15.4 kDa), binds to HER2 with an affinity of 3 nmol/L and might be used for the imaging of HER2 expression. The use of 99mTc might improve the availability of the labeled conjugate, and Tc(I)-carbonyl chemistry enables the site-specific labeling of the histidine tag on the Affibody molecule. The goals of the present study were to prepare 99mTc-labeled His6-(ZHER2:4)2 and to evaluate its targeting properties compared with the targeting properties of 125I-4-iodobenzoate-His6-(ZHER2:4)2 [125I-His6-(ZHER2:4)2]. METHODS: The labeling of His6-(ZHER2:4)2 with 99mTc was performed with an IsoLink kit. The specificity of 99mTc-His6-(ZHER2:4)2 binding to HER2 was evaluated in vitro with SK-OV-3 ovarian carcinoma cells. The comparative biodistributions of 99mTc-His6-(ZHER2:4)2 and 125I-His6-(ZHER2:4)2 in tumor-bearing BALB/c nu/nu mice were determined. RESULTS: The labeling yield for 99mTc-His6-(ZHER2:4)2 was approximately 60% (50 degrees C), and the radiochemical purity was greater than 97%. The conjugate was stable during storage and under histidine and cysteine challenges and demonstrated receptor-specific binding. The biodistribution study demonstrated tumor-specific uptake levels (percentage injected activity per gram of tissue [%IA/g]) of 2.6 %IA/g for 99mTc-His6-(ZHER2:4)2 and 2.3 %IA/g for 125I-His6-(ZHER2:4)2 at 4 h after injection. Both conjugates provided clear imaging of SK-OV-3 xenografts at 6 h after injection. The tumor-to-nontumor ratios were much more favorable for the radioiodinated Affibody. CONCLUSION: The use of Tc(I)-carbonyl chemistry enabled us to prepare a stable, site-specifically labeled 99mTc-His6-(ZHER2:4)2 conjugate that was able to bind to HER2-expressing cells in vitro and in vivo. The indirectly radioiodinated conjugate provided better tumor-to-liver ratios. The labeling of Affibody molecules with 99mTc should be investigated further. 相似文献
102.
103.
104.
Can Electrocardiographic Criteria Predict Adverse Cardiac Events and Positive Cardiac Markers? 总被引:5,自引:0,他引:5
Andra L. Blomkalns MD Christopher J. Lindsell PhD Abhinav Chandra MD Mary E. Osterlund MD W. Brian Gibler MD Charles V. Pollack MS MD Brian R. Tiffany MD PhD Judd E. Hollander MD James W. Hoekstra MD 《Academic emergency medicine》2003,10(3):205-210
OBJECTIVES: To determine electrocardiogram (ECG) predictors of positive cardiac markers and short-term adverse cardiac events in an undifferentiated chest pain population presenting to emergency departments (EDs). The authors hypothesized that specific ECG findings, other than those previously identified in higher-risk populations, would be predictive of cardiac outcomes and positive cardiac markers. METHODS: This study used data from a prospectively collected, retrospectively analyzed Internet-based data registry of undifferentiated chest pain patients (i*trACS). Logistic regression modeling was performed to determine the ECG findings that were predictive of 1) positive cardiac markers and 2) short-term adverse cardiac events. RESULTS: ST-segment elevation (STE), ST-segment depression (STD), pathological Q-waves (PQW), and T-wave inversion were associated with increased odds of percutaneous coronary intervention or catheterization, myocardial infarction, or coronary artery bypass grafting. The odds of creatine kinase-MB (CK-MB) measuring positive were increased if STE, STD, or PQW were present [odds ratio (OR) 2.495, 2.582, and 1.295, respectively]. A right bundle branch block tended to decrease the odds of CK-MB measuring positive (OR 0.658). A similar pattern of results was observed for troponin I (OR 3.608 for STE, 3.72 for STD, 1.538 for PQW). Troponin T showed an increased odds of measuring positive if any of STE, STD, left bundle branch block, or T-wave inversion were evident (OR 2.313, 2.816, 1.80, and 1.449, respectively). CONCLUSIONS: Initial ECG criteria can be used to predict short-term cardiac outcomes and positive cardiac markers. These findings can be important aids in the risk-stratification and aggressive treatment regimens of chest pain patients presenting to EDs. 相似文献
105.
106.
107.
108.
109.
Ziprasidone is an atypical antipsychotic with a unique receptor-binding profile. Currently, ziprasidone is approved by the US Food and Drug Administration for the acute treatment of psychosis in schizophrenia and mania in bipolar disorder. When compared to certain other atypical antipsychotics, ziprasidone appears to have a relatively benign side effect profile, especially as regards metabolic effects eg, weight gain, serum lipid elevations and glucose dysregulation. Taken together, these data suggest that ziprasidone may be a first line treatment for patients with bipolar mania. However, ziprasidone is a relatively new medication for which adverse events after long-term use and/or in vulnerable patient populations must be studied. Unstudied areas of particular importance include the efficacy and safety of ziprasidone in the treatment of bipolar depression and relapse prevention of mania as, well as in the subpopulations of pregnant women, the elderly and pediatric patients. The emergence of mania in patients taking ziprasidone is another topic for further study. 相似文献
110.
Charles Seydoux Danièle Gillard Berguer Eric Eeckhout Frank Stumpe Michel Hurni Patrick Ruchat Hossein Sadeghi Jean-Jacques Goy 《Transplant international》1996,9(4):433-436
Transplant atherosclerotic coronary disease remains the leading cause of death in heart transplant recipients. We report the first case of coronary stent implantation in a heart graft for epicardial focal stenosis. Due to the lower rate of restenosis after stenting in the native coronary artery, we suggest that coronary stenting be considered an acceptable, first intention therapeutic option instead of angioplasty alone whenever possible. 相似文献